TiumBio Statistics

Total Valuation

TiumBio has a market cap or net worth of KRW 184.61 billion. The enterprise value is 187.61 billion.

Market Cap	184.61B
Enterprise Value	187.61B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TiumBio has 27.68 million shares outstanding. The number of shares has increased by 4.33% in one year.

Current Share Class	27.68M
Shares Outstanding	27.68M
Shares Change (YoY)	+4.33%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	35.39%
Owned by Institutions (%)	0.04%
Float	17.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.80
PB Ratio	3.80
P/TBV Ratio	5.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.99
EV / Sales	20.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.19

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.76.

Current Ratio	1.95
Quick Ratio	1.64
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-2.60
Interest Coverage	-3.75

Financial Efficiency

Return on equity (ROE) is -25.94% and return on invested capital (ROIC) is -13.80%.

Return on Equity (ROE)	-25.94%
Return on Assets (ROA)	-11.74%
Return on Invested Capital (ROIC)	-13.80%
Return on Capital Employed (ROCE)	-24.83%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +68.43% in the last 52 weeks. The beta is 0.64, so TiumBio's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+68.43%
50-Day Moving Average	6,603.20
200-Day Moving Average	5,175.78
Relative Strength Index (RSI)	47.70
Average Volume (20 Days)	406,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TiumBio had revenue of KRW 9.32 billion and -11.73 billion in losses. Loss per share was -441.55.

Revenue	9.32B
Gross Profit	7.91B
Operating Income	-18.57B
Pretax Income	-13.53B
Net Income	-11.73B
EBITDA	-14.91B
EBIT	-18.57B
Loss Per Share	-441.55

Full Income Statement

Balance Sheet

The company has 45.27 billion in cash and 36.95 billion in debt, giving a net cash position of 8.32 billion or 300.43 per share.

Cash & Cash Equivalents	45.27B
Total Debt	36.95B
Net Cash	8.32B
Net Cash Per Share	300.43
Equity (Book Value)	48.57B
Book Value Per Share	1,391.50
Working Capital	27.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.10 billion and capital expenditures -115.68 million, giving a free cash flow of -14.22 billion.

Operating Cash Flow	-14.10B
Capital Expenditures	-115.68M
Free Cash Flow	-14.22B
FCF Per Share	-513.75

Full Cash Flow Statement

Margins

Gross margin is 84.80%, with operating and profit margins of -199.18% and -125.81%.

Gross Margin	84.80%
Operating Margin	-199.18%
Pretax Margin	-145.13%
Profit Margin	-125.81%
EBITDA Margin	-159.90%
EBIT Margin	-199.18%
FCF Margin	n/a

Dividends & Yields

TiumBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.33%
Shareholder Yield	-4.33%
Earnings Yield	-6.35%
FCF Yield	-7.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TiumBio has an Altman Z-Score of 0.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.76
Piotroski F-Score	3